Arby’s Brings the Meats to Saudi Arabia
Arby’s, one of the largest restaurant chains in the United States, announced today the opening of its first restaurant in Riyadh on Monday, May 1, featuring a menu that mixes U.S. favorites with exclusive items guests can’t get anywhere else in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230508005284/en/
Arby’s, one of the largest restaurant chains in the United States, announced the opening of its first restaurant in Riyadh in the Kingdom of Saudi Arabia. (Photo: Business Wire)
“Arby’s entry into Saudi Arabia is another exciting milestone for the brands international growth story,” said Michael Haley, President and Managing Director of International for Inspire Brands. “We are very pleased with our Dunkin’ collaboration with Shahia Foods and are excited to expand our portfolio and bring our authority in meat quality and flavor to new guests in a rapidly growing region.”
Shahia Foods Limited Company is one of the region's premier multi-unit restaurant operators and the master franchisee for Dunkin' in Saudi Arabia and Bahrain. Saud Abdullah Al Athel, chief executive officer of Shahia Foods Limited Company, has had his eye on bringing Arby’s to the Kingdom given its unique menu and attention to quality. Shahia Foods operates more than 700 Dunkin' locations across Saudi Arabia, Bahrain and Germany, with plans for continued development across all markets.
Arby’s Riyadh menu features 10 high-quality meat stacks made by hand at the restaurant every day. Each stack is specially designed to bring out the best flavors in our meats, with multiple layers of freshly-sliced protein, served warm with melted cheeses, vegetables, sauces and other delicious toppings on toasted buns. Like its menu in the U.S., guests in Riyadh can enjoy a variety of meats, from tender roast beef sliced to order, to beef brisket smoked for many hours over wood fire, to marinated smokey pulled chicken sizzling with flavor. And to complement your stack, Arby’s offers signature sides like seasoned Curly Fries, crispy onion rings and cheese sticks.
Special menu items that can only be found on the menu in the Kingdom of Saudi Arabia include a Smoked Brisket Philly, which builds on Arby’s signature beef brisket with the addition of roasted vegetables and melted swiss cheese, and a Smokey Barbeque Chicken sandwich with juicy, pulled chicken marinated to perfection in warm shawarma spices and drenched in Arby’s Smoky BBQ sauce.
“Adapting restaurants for international tastes is always a fun challenge, and we’re excited to share what makes Arby’s such a unique and celebrated brand in the U.S. with what are sure to be craveable new favorites,” said Saud Abdullah Al Athel, chief executive officer of Shahia Foods Limited Company. “The team worked tirelessly to create a dining experience and menu offering that will resonate strongly with Saudi guests while firmly rooted in the original Arby’s experience.”
Arby’s now operates 180 locations across eight countries outside the U.S., with plans for further growth in the Kingdom of Saudi Arabia and Southeast Mexico in the coming months.
Arby’s is located on Uthman lbn Affan Road in close proximity to Al Nakheel Mall. The restaurant is 270 m2 with a drive-thru and dine-in seating for up to 70 guests.
For more information about Arby’s or to view the menu in the Kingdom of Saudi Arabia, visit www.arbys.sa or follow us on Facebook @arbyssa, Instagram @arbyssa or Tik Tok @arbyssa. Watch these channels for exciting Grand Opening events and giveaways in the coming days!
About Arby’s
Arby’s, founded in 1964, is the first nationally franchised sandwich restaurant brand in the U.S., with more than 3,400 restaurants worldwide. Its international footprint includes 180 restaurants in eight countries. Starting with its iconic freshly sliced roast beef sandwiches, Arby’s continues to offer one of the most innovative and diverse menus in the quick-service restaurant industry, with more than 30 unique sandwiches and 8 different types of protein. Arby’s global Support Center is located in Atlanta, Georgia. For more information, visit Arbys.com
About Inspire Brands
Inspire Brands is a multi-brand restaurant company whose portfolio includes more than 32,000 Arby’s, Baskin-Robbins, Buffalo Wild Wings, Dunkin’, Jimmy John’s, and SONIC Drive-In locations worldwide, including more than 9,200 restaurants outside the United States. The company was founded in 2018 and is headquartered in Atlanta, Georgia. For more information, visit InspireBrands.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230508005284/en/
Contact information
Inspire Brands Communications Team
press@inspirebrands.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
